Sunday, April 10, 2016

BRIEF-SOBI: COMP recommends that Alprolix maintains orphan designation

* COMP recommends that Alprolix maintains orphan designation for treatment of haemophilia b Source text for Eikon: Further company coverage:











Read more

No comments:

Post a Comment